eGenesis is developing genome-engineered organs aimed at addressing the global shortage of transplantable organs and improving treatment options for patients suffering from organ failure.
eGenesis is developing genome-engineered organs aimed at addressing the global shortage of transplantable organs and improving treatment options for patients suffering from organ failure.
<iframe src="https://hindustansphere.com/embed/cluster/67c42110d88bc42bd812e967a8a0644b608ba80a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn"></iframe>
